Protalix BioTherapeutics, Inc. (PLX): Weighted Average Diluted Shares
78.55M
Year ended 2025-12-31
+17.5%
3-year compound annual growth
| Period ended | Weighted Average Diluted Shares | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | 78.55M | -3.1% | 2026-03-18, From 2025-01-01 |
| 2024-12-31 | 81.06M | -1.7% | 2026-03-18, From 2024-01-01 |
| 2023-12-31 | 82.42M | +70.0% | 2026-03-18, From 2023-01-01 |
| 2022-12-31 | 48.47M | +9.8% | 2025-03-17, From 2022-01-01 |
| 2021-12-31 | 44.14M | n/c | 2024-03-14, From 2021-01-01 |
| 2020-12-31 | 29.15M | n/c | 2023-02-27, From 2020-01-01 |
| 2019-12-31 | 14.84M | n/a | 2022-03-31, From 2019-01-01 |